Using weighted gene coexpression network analysis to analyze the RNA sequencing data and clinicopathological characteristics of large samples of AML patients, it was found that the high expression of PLA2G4A was related to adverse overall survival (33). The gene discussed is PLA2G4A; the disease is acute myeloid leukemia.